1. Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models
   Hongkui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
2. The Research on the Treatment of Metastatic Skin Cutaneous Melanoma by Huanglian Jiedu Decoction Based on the Analysis of Immune Infiltration Analysis
   Ding Li et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Antitumor activity of flavonoids from Alpinia officinarum hance on gastric cancer
   Mirensha Yakufu et al, 2021, European Journal of Inflammation CrossRef
4. STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
   Mehrdokht Sadrkhanloo et al, 2022, Pharmacological Research CrossRef
5. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy
   Lin Chen et al, 2024, European Journal of Pharmacology CrossRef
6. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
   Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
7. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms
   Fanming Kong et al, 2023, Chinese Herbal Medicines CrossRef
8. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
   Sara Molenda et al, 2023, Cancers CrossRef
9. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway
   Cai-Zhi Yang et al, 2023, Journal of Ethnopharmacology CrossRef
10. Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
    Sareshma Sudhesh Dev et al, 2023, Journal of Functional Foods CrossRef
11. Advances in the synergistic and toxic attenuating effect of traditional Chinese medicine in cancer treatment
    Jiao CHEN et al, 2022, SCIENTIA SINICA Vitae CrossRef
12. “Huanglianjiedu Decoction” Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways
    Shu Dong, MD et al, 2024, Journal of Evidence-Based Integrative Medicine CrossRef